Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Litwin

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
Scientific Reports|January 7, 2026
Abnormal epigenetic aging of epigenetic outliers in normal colon mucosa from colorectal cancer patientsBryant M Schultz, Olorunfemi Ayeotan, Juie N Rana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2004
Simultaneous expression of furin and vascular endothelial growth factor in human oral tongue squamous cell carcinoma progressionRicardo López de Cicco, James C Watson, Daniel E Bassi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2013
Reply to S. Buti and S. CulineYu-Ning Wong, Elizabeth R Plimack, Samuel Litwin, et al.
Plos One|November 12, 2014
Combining anti-ERBB3 antibodies specific for domain I and domain III enhances the anti-tumor activity over the individual monoclonal antibodiesJimson W D'Souza, Smitha Reddy, Lisa E Goldsmith, et al.
Cancer Research|August 17, 2005
PACE4 expression in mouse basal keratinocytes results in basement membrane disruption and acceleration of tumor progressionDaniel E Bassi, Ricardo Lopez De Cicco, Jonathan Cenna, et al.
Cancer Biology & Therapy|April 2, 2019
Targeted blockade of HSP90 impairs DNA-damage response proteins and increases the sensitivity of ovarian carcinoma cells to PARP inhibitionRashid Gabbasov, I Daniel Benrubi, Shane W O'Brien, et al.
Plos One|January 5, 2010
Induction of ovarian leiomyosarcomas in mice by conditional inactivation of Brca1 and p53Bridget A Quinn, Tiffany Brake, Xiang Hua, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|November 14, 2017
Optimizing donor site closure following bilateral breast reconstruction with abdominal-based free flapsNoelle M Messina, Kristie Rossi, Lisa M Wetherhold, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 23, 2003
Hepatocyte turnover during resolution of a transient hepadnaviral infectionJesse Summers, Allison R Jilbert, Wengang Yang, et al.
Cancer Research|July 3, 2008
Improved therapeutic results by pretargeted radioimmunotherapy of non-Hodgkin's lymphoma with a new recombinant, trivalent, anti-CD20, bispecific antibodyRobert M Sharkey, Habibe Karacay, Samuel Litwin, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Scientific Reports|January 7, 2026
Abnormal epigenetic aging of epigenetic outliers in normal colon mucosa from colorectal cancer patientsBryant M Schultz, Olorunfemi Ayeotan, Juie N Rana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2004
Simultaneous expression of furin and vascular endothelial growth factor in human oral tongue squamous cell carcinoma progressionRicardo López de Cicco, James C Watson, Daniel E Bassi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2013
Reply to S. Buti and S. CulineYu-Ning Wong, Elizabeth R Plimack, Samuel Litwin, et al.
Plos One|November 12, 2014
Combining anti-ERBB3 antibodies specific for domain I and domain III enhances the anti-tumor activity over the individual monoclonal antibodiesJimson W D'Souza, Smitha Reddy, Lisa E Goldsmith, et al.
Cancer Research|August 17, 2005
PACE4 expression in mouse basal keratinocytes results in basement membrane disruption and acceleration of tumor progressionDaniel E Bassi, Ricardo Lopez De Cicco, Jonathan Cenna, et al.
Cancer Biology & Therapy|April 2, 2019
Targeted blockade of HSP90 impairs DNA-damage response proteins and increases the sensitivity of ovarian carcinoma cells to PARP inhibitionRashid Gabbasov, I Daniel Benrubi, Shane W O'Brien, et al.
Plos One|January 5, 2010
Induction of ovarian leiomyosarcomas in mice by conditional inactivation of Brca1 and p53Bridget A Quinn, Tiffany Brake, Xiang Hua, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|November 14, 2017
Optimizing donor site closure following bilateral breast reconstruction with abdominal-based free flapsNoelle M Messina, Kristie Rossi, Lisa M Wetherhold, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 23, 2003
Hepatocyte turnover during resolution of a transient hepadnaviral infectionJesse Summers, Allison R Jilbert, Wengang Yang, et al.
Cancer Research|July 3, 2008
Improved therapeutic results by pretargeted radioimmunotherapy of non-Hodgkin's lymphoma with a new recombinant, trivalent, anti-CD20, bispecific antibodyRobert M Sharkey, Habibe Karacay, Samuel Litwin, et al.
Pageof 8